New Invitation for Expression of Interest (EOI) to manufacturers of Antimalarial Medicines Published

New Invitation for Expression of Interest (EOI) to manufacturers of Antimalarial Medicines.

The following products/formulations were added (marked in bold under the EOI sections):

3. Artemisinin-based single-ingredient formulations

• Artesunate, powder for injection 30 mg; 60 mg; 120 mg; 180 mg (vial) - Addition of  "180 mg"

5 . Other antimalarial medicines

• Sulfadoxine/Pyrimethamine

  • tablets 500 mg/25 mg (scored, or scored and dispersible) - Addition of  "or scored and dispersible"

• Quinine Injection, 300 mg/mL (hydrochloride) in 2 mL ampoule